Skip to main content

Table 2 Comparison of stool microscopic outcomes between Intervention and Placebo groups of patients with shigellosis a

From: Efficacy of sodium butyrate adjunct therapy in shigellosis: a randomized, double-blind, placebo-controlled clinical trial

  No. of patient improved n (%) compared to day 1 Odds ratiob(95%CI) p valueb
Microscopic features in stool Intervention group n = 39 Placebo group n = 37   
RBC at day-2 29 (74.4) 22 (59.5) 1.85 (0.7-4.9) 0.22
RBC at day-3 32 (82)) 31 (83.8) 0.88 (0.3-2.9) 1.0
Pus cell at day-2 30 (76.9) 17 (45.9) 3.72 (1.4-10) 0.009
Pus cell at day-3 32 (82) 30 (81.1) 1.1 (0.3-3.4) 1.0
Macrophage at day-2 32 (82) 22 (59.5) 3.12 (1.1-8.9) 0.043
Macrophage at day-3 38 (97.4) 34 (91.9) 3.3 (0.3-33.8) 0.35
  1. Abbreviations: RBC Red blood cell, CI Confidence interval.
  2. aData are given as number of patients (% of total patients in each group).
  3. bChi-square test was used to compare between the groups. Significance: p≤ 0.05.